Model validity for preclinical studies in precision medicine: precisely how precise do we need to be?

Area of Science:

• Biomedical research
• Genomics
• Translational medicine

Background:

• Personalized medicine aims to tailor treatments to individual patients based on genetic makeup and environmental factors.
• While successful in some areas like oncology, applying precision medicine to diseases lacking effective treatments remains a challenge.
• Experimentally tractable models are essential for advancing research in these complex conditions.

Purpose of the Study:

• To discuss considerations for developing and improving "precision models" for disease research.
• To explore the required level of precision and circumstances for their application.
• To enhance the predictive validity of models for better patient outcomes.

Main Methods:

• Discussing the principles and engineering of genetically modified systems for disease modeling.
• Analyzing the role of genetic background, risk alleles, and gene-environment interactions.
• Evaluating the recapitulation of human pathophysiology in experimental models.

Main Results:

• Genetically engineered systems and increased understanding of genetic/environmental factors enable more sophisticated and precise disease models.
• These advanced models better reproduce complex patient conditions.
• Successful translation of research findings from precision models to effective patient treatments has been observed.

Conclusions:

• Precision models are vital for advancing personalized medicine, especially for diseases without current effective treatments.
• Continuous improvements in genetic engineering and a deeper understanding of disease complexity enhance model predictability.
• The development and application of sophisticated precision models hold significant promise for future therapeutic breakthroughs.